Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Global Real-World Evidence Study on the Long-term Effectiveness of ABBV-951 in Advanced Parkinson´s Disease in Routine Clinical Practice (ROSSINI: Real-world Outcomes With continuouS Subcutaneous Levodopa INfusIon)

NCT06107426 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06107426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06107426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Global Real-World Evidence Study on the Long-term Effectiveness of ABBV-951 in Advanced Parkinson´s Disease in Routine Clinical Practice (ROSSINI: Real-world Outcomes With continuouS Subcutaneous Levodopa INfusIon)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Active, not recruiting
Start date
January 24, 2024
Completion date
May 31, 2029
Enrollment
427 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease (pd)